You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
熱點掃描 | 物業管理板塊普遍下挫

uSMART盈立智投11月5日消息,截止發稿,港股三大指數齊跌,恆生指數跌1.29%報24898.92點,成交額301.57億;恆生科技指數跌1.36%報6288.61點,成交額68.76億;紅籌指數跌0.54%報3737.50點,成交額6.06億。

板塊方面:

港股醫藥股多數走低,康希諾生物跌3.74%,藥明康德跌2.48%,藥明康德跌2.21%,昭衍新藥跌1.13%。

港股物業管理板塊普遍下挫,奧園健康現跌23.59%,世茂服務跌5.7%,融創服務跌4.85%,碧桂園服務跌1.51%。

港股石油股表現疲軟,中國石油股份跌3.31%,中海油田服務跌2.38%,中國石油化工股份跌1.83%,中國海洋石油跌1.68%。

個股方面:

佳兆業集團、佳兆業美好、佳兆業健康、佳兆業資本在香港暫停交易。

新股鷹瞳科技上市首日破發,現跌近10%,報67.6港元,發行價爲75.1港元/股。

奧園健康跌14.75%,此前公告稱正與若幹獨立第三方就可能出售提供物業管理及其他相關服務的若幹附屬公司的權益進行初步討論。

新股三葉草生物首日上市,現漲0.15%,報13.4港元,發行價爲13.38港元/股。

萬隆控股集團獲大股東雲南白藥溢價約3.64%提全購,11月5日復牌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account